Analysis suggests that the research and development of DMTs and non-motor therapies will diversify Parkinson's treatment ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has identified a potential biomarker of Parkinson's disease progression.

Net cash used in operating and investing activities was $45.2 million and $102.5 million for the third quarter and first nine months of 2024, respectively; quarter-end cash and restricted cash positio ...

Third quarter results highlight strong operational performance across key value drivers: YUPELRI® (revefenacin) net sales of $62.2 million, recognized by Viatris ...

Researchers at Tel Aviv University (TAU) discovered a new factor in the pathology of Parkinson's disease, which in the future ...

Israeli scientists have identified a promising new factor in the pathology of Parkinson’s disease that could pave the way for ...

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

In 1989 a patient with myalgic encephalomyelitis (ME) came to see Dr Raymond Perrin in his capacity as an osteopath. The man ...

Nearly one million people in the U.S. are living with Parkinson's Disease. Playhouse Square is rolling out a new program to ...

Molson Coors Beverage Co. Cl B $61.89 1.39 2.30% ...